NASHVILLE (AP) — Tennessee will receive a portion of a $500 million settlement with generic drug manufacturer Ranbaxy.

Tennessee Attorney General Bob Cooper announced Thursday that Tennessee will receive more than $5.5 million. The settlement resolved claims that Ranbaxy sold inferior drugs and made false statements about how they were made.

The claim sprang from a whistleblower complaint that alleged the company manufactured, distributed and sold generic pharmaceuticals that failed to meet Food and Drug Administration standards for strength, purity and quality.

The 26 products in question were made at two plants in India between 2003 and 2010.

A team from the National Association of Medicaid Fraud Control Units conducted the settlement negotiations with Ranbaxy on behalf of the states.